trial · primary record
BGB-16673
Chronic Lymphocytic Leukemia (CLL)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2033-07-01 |
| Primary endpoint | Safety and Adverse Events (AEs) |
| Registry ID | NCT07508995 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:31:54.729Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07508995
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.